Serina Therapeutics, Inc. (SER)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch SER
See up to 3 months of SER. The 7-day demo opens the 1M and 3M ranges and puts SER on your watchlist.
Start 7-day demoLatest SER insider trades
About Serina Therapeutics, Inc. (SER)
The SEC lists Serina Therapeutics, Inc. under CIK 0001708599, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector. A registration statement was filed on 24 August 2026. No offering has priced.
SER Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 30,500 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SER insider transactions (Form 4)
6356 Form 4 filings on record, the earliest from Dec 19, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Farrell Simon - Director | Grant or award | Stock Option (right to buy) | 30,500 | $0.00 | - | |
| Stephen K. Brannan - Director | Open-market purchase | Common Stock | 1,000 | $2.03 | $2K | |
| Jay Venkatesan - Director | Other | Series A Convertible Preferred Stock | 96,525 | $2.25 | $217K | |
| Jay Venkatesan - Director | Open-market purchase | Common Stock | 589 | $1.78 | $1K | |
| Jay Venkatesan - Director | Other | Common Stock | 224,152 footnote F2 | $2.25 | $504K | |
| Jay Venkatesan - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| ||||||
| Gregory Bailey - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Gregory Bailey - Director | Grant or award | Redeemable Warrants | 3,333,333 footnote F5 | $0.00 | - | |
| Gregory Bailey - Director | Other | Series A Convertible Preferred Stock | 762,548 | $2.25 | $1.72M | |
| Gregory Bailey - Director | Other | Common Stock | 1,770,805 footnote F1 | $2.25 | $3.98M | |
| Gregory Bailey - Director | Other | Common Stock | 6,666,667 footnote F3 | $2.25 | $15.00M | |
| ||||||
| Stephen K. Brannan - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Karen J. Wilson - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Richard Peter Marshall - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Karen J. Wilson - Director | Open-market purchase | Common Stock | 5,000 | $1.77 | $9K | |
| Karen J. Wilson - Director | Open-market purchase | Common Stock | 5,100 | $1.75 | $9K | |
| Steven A. Ledger - Officer | Grant or award | Common Stock | 10,100 | $1.93 footnote F1 | $19K | |
| ||||||
 Srini Tenjarla - Officer | Grant or award | Stock Option (right to buy) | 85,558 | $0.00 | - | |
| Steven A. Ledger - Officer | Grant or award | Stock Option (right to buy) | 380,825 | $0.00 | - | |
 Gregory S. Curhan - Officer | Grant or award | Stock Option (right to buy) | 123,019 | $0.00 | - | |
| Randall Moreadith - Officer | Grant or award | Stock Option (right to buy) | 85,558 | $0.00 | - | |
| Karen J. Wilson - Director | Open-market purchase | Common Stock | 10,000 | $1.77 footnote F1 | $18K | |
| Karen J. Wilson - Director | Open-market purchase | Common Stock | 10,000 | $1.93 footnote F2 | $19K | |
| ||||||
| Richard Peter Marshall - Director | Open-market purchase | Common Stock | 12,183 | $1.65 footnote F1 | $20K | |
| ||||||
| Gregory Bailey - Director | Grant or award | Common Stock | 59,667 footnote F1 | $1.94 | $116K | |
| ||||||
| Jay Venkatesan - Director | Grant or award | Common Stock | 7,553 footnote F1 | $1.94 | $15K | |
| ||||||
| Randall Moreadith - Officer | Option exercise | Common Stock | 6,500 | $0.06 | $390 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 6,500 | $2.86 footnote F1 | $19K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 6,500 | $0.00 | - | |
| ||||||
| Randall Moreadith - Officer | Option exercise | Common Stock | 39,000 | $0.06 | $2K | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 39,000 | $2.50 | $98K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 39,000 | $0.00 | - | |
| Randall Moreadith - Officer | Grant or award | Stock Option (right to buy) | 69,000 | $0.00 | - | |
| Srini Tenjarla - Officer | Grant or award | Stock Option (right to buy) | 69,000 | $0.00 | - | |
 Simba Gill - Director | Grant or award | Stock Option (right to buy) | 92,000 | $0.00 | - | |
| Steven A. Ledger - Officer | Grant or award | Stock Option (right to buy) | 230,100 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 6,500 | $0.06 | $390 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 6,500 | $3.03 footnote F1 | $20K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 6,500 | $0.00 | - | |
| ||||||
| Randall Moreadith - Officer | Option exercise | Common Stock | 6,500 | $0.06 | $390 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 6,500 | $3.57 footnote F1 | $23K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 6,500 | $0.00 | - | |
| ||||||
| Randall Moreadith - Officer | Option exercise | Common Stock | 2,500 | $0.06 | $150 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 2,500 | $2.95 | $7K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 2,500 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 2,000 | $0.06 | $120 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 2,000 | $3.07 | $6K | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 2,000 | $0.06 | $120 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 2,000 | $3.00 | $6K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 2,000 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 2,000 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 1,700 | $0.06 | $102 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 1,700 | $3.26 footnote F1 | $6K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 1,700 | $0.00 | - | |
| ||||||
| Randall Moreadith - Officer | Open-market sale | Common Stock | 1,500 | $3.91 footnote F1 | $6K | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 5,000 | $0.06 | $300 | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 1,500 | $0.06 | $90 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 5,000 | $3.52 footnote F2 | $18K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 1,500 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 5,000 | $0.00 | - | |
| ||||||
| Randall Moreadith - Officer | Option exercise | Common Stock | 5,965 | $0.06 | $358 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 5,965 | $3.90 footnote F1 | $23K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 5,965 | $0.00 | - | |
| ||||||
Item 5.03, 9.01
Item 8.01, 9.01
Item 1.01, 3.02, 9.01
Item 2.02, 9.01
SER insider trading FAQ
What is the latest insider trade for SER?
Serina Therapeutics, Inc. (SER) had 1 insider filing in the last 90 days, with the most recent on 2026-07-23. The full record for SER runs to 56 Form 4 filings, the earliest from 2024-12-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SER stock?
No insider purchases of SER were filed in the last 90 days. 8 purchases are on record for this company.
How many insiders are selling SER stock?
No insider sales of SER were filed in the last 90 days. 32 sales are on record for this company.
Where can I see SER SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SER Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Farrell Simon view on EDGAR
- - Stephen K. Brannan view on EDGAR
- - Jay Venkatesan view on EDGAR
- - Gregory Bailey view on EDGAR
- - Stephen K. Brannan view on EDGAR
- - Karen J. Wilson view on EDGAR
- - Richard Peter Marshall view on EDGAR
- - Karen J. Wilson view on EDGAR
- - Steven A. Ledger view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SER's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SER with a 7-day demo
- SER on your watchlist
- Every SER Form 4 filing on record
- Up to 3 months of SER price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
